These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18897990)

  • 1. Responses of human subjects to vaccines in saline-in-mineral oil emulsion; Shigella paradysenteriae vaccines.
    MUDD S; HALBERT SP; SMOLENS J
    J Immunol; 1948 Jan; 58(1):33-9. PubMed ID: 18897990
    [No Abstract]   [Full Text] [Related]  

  • 2. The antigenicity of Shigella paradysenteriae (Flexner) in saline-in-mineral-oil emulsion.
    HALBERT SP; MUDD S; SMOLENS J
    Proc Soc Exp Biol Med; 1945 Oct; 60():17-9. PubMed ID: 21004019
    [No Abstract]   [Full Text] [Related]  

  • 3. The increased antigenicity of Shigella paradysenteriae (Flexner) in saline-in-mineral-oil emulsion; experiments in mice and rabbits.
    HALBERT SP; MUDD S; SMOLENS J
    J Immunol; 1946 Jul; 53(3):291-301. PubMed ID: 20992665
    [No Abstract]   [Full Text] [Related]  

  • 4. The type-specificity of immune protection against Shigella paradysenteriae (Flexner).
    WEIL AJ; FARSETTA K
    J Immunol; 1945 Oct; 51():301-5. PubMed ID: 21003545
    [No Abstract]   [Full Text] [Related]  

  • 5. Invasion by Shigella sonnei of tissues of mice following gavage with viable Shigella.
    COOPER ML; KELLER HM
    Proc Soc Exp Biol Med; 1948 May; 68(1):87-90. PubMed ID: 18863683
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new Shigella paradysenteriae serotype: the 112 type of Cox and Wallace].
    COURTOIS G; VANDEPITTE J
    Ann Soc Belg Med Trop (1920); 1950 Jun; 30(2):149-54. PubMed ID: 15433052
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of rabbit and mouse antisera to Shigella paradysenteriae.
    DOAK BW; HALBERT SP
    J Immunol; 1946 Feb; 52():113-20. PubMed ID: 21018814
    [No Abstract]   [Full Text] [Related]  

  • 8. Responses of human subjects to vaccines in saline-in-mineral oil emulsion; Hemophilis pertussis vaccines.
    MUDD S; FELTON HM; SMOLENS J
    J Immunol; 1948 Jan; 58(1):41-7. PubMed ID: 18897991
    [No Abstract]   [Full Text] [Related]  

  • 9. Field trial of "Shigella flexneri III" vaccine.
    BARNES LA; SMITH AB; DURANT RC; DRESSLER HR
    U S Armed Forces Med J; 1950 Nov; 1(11):1285-97. PubMed ID: 14782322
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of vaccination on purification of the organism from Shigella paradysenteriae].
    LESNIAK SV
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Oct; (10):27-32. PubMed ID: 13282473
    [No Abstract]   [Full Text] [Related]  

  • 11. On the nature of the toxic component of the somatic antigen of Shigella paradysenteriae type Z (Flexner).
    TAL C; GOEBEL WF
    J Exp Med; 1950 Jul; 92(1):25-34. PubMed ID: 15422094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field trial of Shigella flexneri III vaccine. VI. Mouse protective studies.
    BARNES LA; COOPER ML; JEROME EA; DURANT RC; SMITH AB
    J Immunol; 1951 May; 66(5):515-24. PubMed ID: 14832473
    [No Abstract]   [Full Text] [Related]  

  • 14. A field trial of Shigella flexneri III vaccine; serum agglutination studies.
    BENNETT IL; GORDON RS; BARNES LA
    J Infect Dis; 1949; 85(2):180-94. PubMed ID: 18137145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of forms of the dysentery bacillus called type F in the German nomenclature and certain American and British Shigella strains; with a note on dissociation in the Flexner group].
    SEELIGER H
    Z Hyg Infektionskr; 1950; 131(5):509-54. PubMed ID: 14789074
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in dysentery vaccination; immunity in mice injected with vaccines of Shigella.
    COOPER ML; KELLER HM
    J Immunol; 1948 Apr; 58(4):361-8. PubMed ID: 18864081
    [No Abstract]   [Full Text] [Related]  

  • 18. MECHANISM OF THE AUGMENTING ACTION OF MINERAL OIL ON ANTIBODY PRODUCTION : TISSUE REACTIONS AND ANTIBODY RESPONSE TO DYSENTERY VACCINE IN SALINE, AND IN SALINE-LANOLIN-MINERAL OIL EMULSION.
    Ehrich WE; Halbert SP; Mertens E; Mudd S
    J Exp Med; 1945 Oct; 82(5):343-60. PubMed ID: 19871505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
    Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
    Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.